Skip to main content

Be a Part of Our Vitiligo Clinical Trials

Let’s break the stigma of Vitiligo together. Help us discover potential treatments for Vitiligo by enrolling in our Vitiligo clinical trials.

Let’s Overcome


Vitiligo causes white patches or depigmentation of the skin; it is the most common form of vitiligo. It affects around 0.5% – 2% of the population globally. Vitiligo can occur at any age and affects people of all races and ethnicities. Currently limited Vitiligo treatment options include topical steroids, vitamin D3, calcineurin inhibitors, topical immunomodulators, phototherapy, surgical treatments, and camouflage. MetroBoston is conducting clinical trials in vitiligo to determine the safety and efficacy of new potential treatments that may improve skin pigmentation.

Enroll Now

Please provide your contact information only.
Thank you for your interest in participating in our research study. Please remember that filling out the enrollment form does not guarantee your selection for the study. You will only be considered for participation by our team if you fit the study criteria.
Dermatology Clinical Trials in Boston - Vitiligo Clinical Trials Near You in Boston

Safety, efficacy, and Tolerability Evaluation

Eligibility Criteria

Enroll in our Vitiligo clinical trials near you in Boston and help us untether the complications of Vitiligo.

Calendar Vector


10-19 Years & Above

Male Gender Vector


Male and Female

Status Vector

Current Status


Location Vector

Total Studies


Map Point Vector


Brighton – Boston

Frequently Asked Questions

What is Vitiligo?

Vitiligo is a long-term skin condition characterized by the loss of pigment-producing cells, resulting in the development of white patches or depigmentation on various parts of the body.

What causes Vitiligo?

The exact cause of vitiligo is not fully understood, but it is believed to involve a combination of genetic, autoimmune, and environmental factors.

What is the cure for Vitiligo?

There is no known cure for Vitiligo. However, MetroBoston is conducting Vitiligo Clinical Trials to find possible treatments for the condition.

What are the complications of Vitiligo?

Some of the complications accompanying Vitiligo may be skin sensitivity to the sun, effects on mental health, or autoimmune disorders.

Am I at an increased risk of skin cancer due to Vitiligo?

Individuals with vitiligo generally have a lower risk of developing skin cancer in the areas affected by depigmentation. Melanocytes are reduced or absent in vitiligo-affected skin patches. As a result, these areas are less likely to develop melanoma, a type of skin cancer originating from melanocytes.